Perrigo | PRGO - Operating Profit



Perrigo reported $55.6M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
AbbVie USD 5.72B 1.98B Jun/2025
Abbott USD 2.07B 415M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Dr.Reddys Laboratories INR 17.48B 2.04B Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
J&J USD 6.94B 6.69B Jun/2025
Merck USD 6.36B 494M Jun/2025
Nestle CHF 7.14B 136M Jun/2025
Pacira USD 10.23M 8.24M Jun/2025
Perrigo USD 55.6M 23.8M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Prestige Brands USD 71.76M 16.67M Jun/2025
Reckitt Benckiser GBP 747M 92M Dec/2024
Sanofi EUR 1.71B 573M Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
Teva Pharmaceutical Industries USD 899M 380M Jun/2025
Xeris Pharmaceuticals USD 4.48M 2.8M Jun/2025
Zoetis USD 1.02B 205M Jun/2025